Karim Fizazi, MD, PhD
Karim Fizazi, MD, PhD
Karim Fizazi is a medical oncologist at Institut Gustave Roussy and full professor in oncology at the University of Paris Saclay in Villejuif, France. Fizazi is the president of the French Groupe d’Etude des Tumeurs Genito-Urinaires (GETUG) and head of the GU oncology group at Gustave Roussy
Disclosures: Amgen, Arvinas, Astellas, AstraZeneca, Bayer, Clovis, CureVac, Daiichi Sankyo, Janssen, MacroGenics, MSD, Novartis (Advanced Accelerator Applications), Orion, Pfizer, and Sanofi.
View content featuring Fizazi:
Developed by EPG Health. This content has been developed independently of the sponsor, Pfizer, which has had no editorial input into the content. EPG Health received funding from the sponsor to help provide healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content. This content is intended for healthcare professionals only.
of interest
are looking at
saved
next event